Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 107.00
-1.00 (-0.93%)
Mar 24, 2026, 1:30 PM CST
Syngen Biotech Revenue
In the year 2025, Syngen Biotech had annual revenue of 2.14B TWD with 6.10% growth. Syngen Biotech had revenue of 479.78M in the quarter ending December 31, 2025, with 1.05% growth.
Revenue
2.14B
Revenue Growth
+6.10%
P/S Ratio
1.36
Revenue / Employee
8.65M
Employees
247
Market Cap
2.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.14B | 122.89M | 6.10% |
| Dec 31, 2024 | 2.01B | 176.41M | 9.60% |
| Dec 31, 2023 | 1.84B | -93.41M | -4.84% |
| Dec 31, 2022 | 1.93B | 459.33M | 31.22% |
| Dec 31, 2021 | 1.47B | 159.83M | 12.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apex Biotechnology | 1.94B |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Genovate Biotechnology | 492.41M |
| Sagittarius Life Science | 346.08M |
| 3D Global Biotech | 324.87M |
| HeXun Biosciences | 290.83M |
| Intech Biopharm | 113.85M |
| GlycoNex Incorporation | 37.86M |